Suppressors of cytokine signaling (SOCS) 1 and SOCS3 interact with and modulate fibroblast growth factor receptor signaling
Author:
Ben-Zvi Tal12, Yayon Avner3, Gertler Arieh2, Monsonego-Ornan Efrat1
Affiliation:
1. Institute of Animal Science, The Volcani Center, Bet Dagan 50250, Israel 2. Institute of Biochemistry, Nutritional Sciences, Faculty of Agricultural, Food and Environmental Quality, The Hebrew University of Jerusalem, Rehovot 76100, Israel 3. ProChon Biotech Ltd, PO Box 1482, Rehovot 76114, Israel
Abstract
Fibroblast growth factor receptor (FGFR) signaling is transduced by the mitogen-activated protein kinase (MAPK) cascade and the signal transducers and activators of transcription (STATs). Suppressors of cytokine signaling (SOCS) proteins are expressed in response to cytokine-inducible stimulation of STAT phosphorylation, acting in a negative-feedback mechanism to hinder the activities of these receptors. However, there are no data concerning the role of SOCS proteins in the regulation of fibroblast growth factor receptor (FGFR) signaling. In the present study, we show that activation of FGFR in chondrocytes induces the expression of SOCS1 and SOCS3 mRNA, and that these proteins are constitutively associated with FGFR3, as demonstrated by co-immunoprecipitation studies. Transfection of cells with FGFR3-GFP and SOCS1-CFP revealed their colocalization, clustered prominently in the perinuclear cytosolic part of the cell. The effect of the interaction between FGFR3 and SOCS1 on receptor activity was investigated in a chondrocytic cell line overexpressing SOCS1. In these cells, STAT1 phosphorylation is repressed, MAPK phosphorylation is elevated and prolonged, and FGFR3 downregulation is attenuated. Expression of osteopontin (OPN), which is directly upregulated by FGF in chondrocytes, was stimulated by lower levels of FGF in cells expressing SOCS1 compared with parental cells. Blocking of MAPK phosphorylation by PD98059 decreased OPN expression in both cell types, but this decrease was more marked in cells expressing SOCS1. The presented results suggest a novel interaction between the SOCS1 and SOCS3 proteins and the FGFR3 signaling pathway.
Publisher
The Company of Biologists
Reference70 articles.
1. Adar, R., Monsonego-Ornan, E., David, P. and Yayon, A. (2002). Differential activation of cysteine-substitution mutants of fibroblast growth factor receptor 3 is determined by cysteine localization. J. Bone Miner. Res.17, 860-868. 2. Basilico, C. and Moscatelli, D. (1992). The FGF family of growth factors and oncogenes. Adv. Cancer Res.59, 115-165. 3. Bellus, G. A., Hefferon, T. W., Ortiz de Luna, R. I., Hecht, J. T., Horton, W. A., Machado, M., Kaitila, I., McIntosh, I. and Francomano, C. A. (1995). Achondroplasia is defined by recurrent G380R mutations of FGFR3. Am. J. Hum Genet.56, 368-373. 4. Ben-Yair, L., Slaaby, R., Herman, A., Cohen, Y., Biener, E., Moran, N., Yoshimura, A., Whittaker, J., De Meyts, P., Herman, B. et al. (2002). Preparation and expression of biologically active prolactin and growth hormone receptors and suppressor of cytokine signaling proteins 1, 2, 3, and 6 tagged with cyan and yellow fluorescent proteins. Protein Expr. Purif.25, 456-464. 5. Boilly, B., Vercoutter-Edouart, A. S., Hondermarck, H., Nurcombe, V. and Le Bourhis, X. (2000). FGF signals for cell proliferation and migration through different pathways. Cytokine Growth Factor Rev.11, 295-302.
Cited by
53 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|